华法林类似物向二硫化物键形成酶,并暗示和氨酸结合的重要残留物
Dariana Chavez1, Gwendolyn Nita Amarquaye1, Adrian Mejia-Santana1
1Department of Biology, Indiana University, Bloomington, Indiana, USA.
The Journal of biological chemistry
|May 18, 2024
概括
确定了针对参与二硫化键形成的细菌或人体酶的华法林类似物. 这项研究使得使用库马林支架开发新型抗凝剂和抗菌剂成为可能.
科学领域:
- 蛋白质的生物化学 蛋白质的生物化学
- 酶学 是一种酶学.
- 药物发现 药物发现
背景情况:
- 在所有生物体中,二硫化物键的形成对蛋白质折叠至关重要.
- 细菌二硫化键被DsbA和DSbB/VKOR酶催化,DSbA引入键,DSbB/VKOR再生DSbA活动.
- 华法林类似物已被确定为细菌DsbB或VKOR的潜在抑制剂.
研究的目的:
- 调查华法林类似物对细菌和哺乳动物VKOR酶的选择性抑制的结构-活性关系.
- 探索使用细菌选新型抗凝剂的潜力.
- 为了确定关键的氨基酸残留物,参与药物结合和酶活性.
主要方法:
- 在大肠杆菌中表达功能人类VKORc1的表达.
- 对华法林类似物进行结构-活性关系分析.
- 通过突变发生和功能测定来识别关键氨基酸残留物.
主要成果:
- 人类VKORc1在大肠杆菌中成功表达和功能,使抗凝剂的细菌查成为可能.
- 一种华法林类似物抑制了细菌DsbB/VKOR和人类VKORc1,而另一种选择性抑制了人类VKORc1.1.
- 库马林环上的特定替代物和两个关键的氨基酸残留物被确定为药物选择性和酶功能的关键.
结论:
- 这项研究提供了对华法林类似物对细菌和哺乳动物VKOR酶的选择性抑制的见解.
- 这些发现有助于设计基于氨酸的新型抗凝固剂和抗菌剂.
- 在DsbB和VKOR酶中发现了一种对新型二硫化键形成至关重要的保存氨基酸残留物.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
Oxidation of Phenols to Quinones
3.0K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.0K
Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699


